Company Mera Pharmaceuticals, Inc. Other OTC
Equities
MRPI
US58732R1032
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Natural Products
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -51.78% |
Sales per region
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Global
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -51.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Benny Doro
PSD | President | 57 | 16/03/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Benny Doro
PSD | President | 57 | 16/03/21 |
Rafi Markarian
BRD | Director/Board Member | 60 | 16/03/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 974 | 0 | 0 | 99.91 % |
Stock B | 1 | 557,799,676 | 557,299,676 ( 99.91 %) | 500,000 ( 0.0896 %) | |
Stock C | 0 | 80 | 0 | 0 |
Company contact information
Mera Pharmaceuticals, Inc.
8275 South Eastern Avenue Suite 200
89123, Las Vegas
+
http://www.merapharma.comSector
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |